Drug profile · INN
fampridine
FAMPYRA
fampridine (FAMPYRA) is a voltage-gated potassium channel blocker.
EMA: approved Nervous system (N07) N07XX07
Patents linked 0
Pipeline programs 8
News articles 0
Drug details — fampridine
- Class
- Nervous system (N07)
- Route
- —
- Patents
- 0
- Programs
- 8
- Data quality
- 0.83
Quick answer
fampridine (FAMPYRA) is a voltage-gated potassium channel blocker.
Key facts
INN fampridine
Brand FAMPYRA
Mechanism Voltage-gated potassium channel blocker
Target Voltage-gated potassium channel
Therapeutic class Nervous system (N07)
ATC code N07XX07
Mechanism of action
Voltage-gated potassium channel blocker
Primary target: Voltage-gated potassium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is fampridine?
fampridine (FAMPYRA) is a voltage-gated potassium channel blocker.
What is the brand name for fampridine?
FAMPYRA is a marketed brand name for fampridine. Check FDA Drugs@FDA for the current US label holder and prescribing information.